Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Segall

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Toxicology Letters|December 1, 1985
In vivo covalent binding of trans-4-hydroxy-2-hexenal to rat liver macromoleculesL D Grasse, M W Lamé, H J Segall
Biomedical & Environmental Mass Spectrometry|March 1, 1988
Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometryC K Winter, H J Segall, A D Jones
Toxicology and Applied Pharmacology|November 1, 1992
Hydrolysis of pyrrolizidine alkaloids by guinea pig hepatic carboxylesterasesS R Dueker, M W Lamé, H J Segall
Experimental Lung Research|April 3, 1999
Manipulation of injury and repair of the alveolar epithelium using two pneumotoxicants: 3-methylindole and monocrotalineL W Woods, D W Wilson, H J Segall
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1982
Covalent binding of two pyrrolizidine alkaloids, senecionine and seneciphylline, to hepatic macromolecules and their distribution, excretion, and transfer into milk of lactating miceD F Eastman, G P Dimenna, H J Segall
Toxicology|November 1, 1990
Excretion and blood radioactivity levels following [14C]senecionine administration in the ratJ E Estep, M W Lamé, H J Segall
Toxicology|March 30, 1993
Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular diseaseL C Pan, D W Wilson, H J Segall
Vascular Pharmacology|March 6, 2007
Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cellsM Ramos, M W Lamé, H J Segall, et al.
Vascular Pharmacology|November 8, 2005
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitroM Ramos, M W Lamé, H J Segall, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Metabolism of [14C]monocrotaline by isolated perfused rat liverM W Lamé, A D Jones, D Morin, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Toxicology Letters|December 1, 1985
In vivo covalent binding of trans-4-hydroxy-2-hexenal to rat liver macromoleculesL D Grasse, M W Lamé, H J Segall
Biomedical & Environmental Mass Spectrometry|March 1, 1988
Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometryC K Winter, H J Segall, A D Jones
Toxicology and Applied Pharmacology|November 1, 1992
Hydrolysis of pyrrolizidine alkaloids by guinea pig hepatic carboxylesterasesS R Dueker, M W Lamé, H J Segall
Experimental Lung Research|April 3, 1999
Manipulation of injury and repair of the alveolar epithelium using two pneumotoxicants: 3-methylindole and monocrotalineL W Woods, D W Wilson, H J Segall
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1982
Covalent binding of two pyrrolizidine alkaloids, senecionine and seneciphylline, to hepatic macromolecules and their distribution, excretion, and transfer into milk of lactating miceD F Eastman, G P Dimenna, H J Segall
Toxicology|November 1, 1990
Excretion and blood radioactivity levels following [14C]senecionine administration in the ratJ E Estep, M W Lamé, H J Segall
Toxicology|March 30, 1993
Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular diseaseL C Pan, D W Wilson, H J Segall
Vascular Pharmacology|March 6, 2007
Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cellsM Ramos, M W Lamé, H J Segall, et al.
Vascular Pharmacology|November 8, 2005
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitroM Ramos, M W Lamé, H J Segall, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Metabolism of [14C]monocrotaline by isolated perfused rat liverM W Lamé, A D Jones, D Morin, et al.
Pageof 7